BioArray Briefs: 2009.01.20

Premium

Coriell Using Affy's DMET in Gene/Drug Interaction Studies

The Coriell Personalized Medicine Collaborative will use Affymetrix's DMET Plus biomarker panel for a national study of markers for drug response, Affy said last week.

The CPMC, a branch of the Coriell Institute for Medical Research, is using the panel to expand studies it has already been conducting with Affy's Genome-Wide Human SNP Array 6.0 to identify genes that are associated with complex health conditions, such as diabetes, cancer, and heart and blood vessel diseases.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.